Haleon (LSE:HLN) Price-to-Operating-Cash-Flow : (As of Apr. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Price-to-Operating-Cash-Flow?

As of today (2024-04-24), Haleon's share price is £3.296. Haleon's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00. Hence, Haleon's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Haleon's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:HLN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.85 Med: 15.25 Max: 22.27
Current: 14.66

During the past 5 years, Haleon's highest Price-to-Operating-Cash-Flow Ratio was 22.27. The lowest was 13.85. And the median was 15.25.

LSE:HLN's Price-to-Operating-Cash-Flow is ranked better than
57.16% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.32 vs LSE:HLN: 14.66

Haleon's Cash Flow from Operations per share for the three months ended in Dec. 2023 was £0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Haleon was 1.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.30% per year.

During the past 5 years, Haleon's highest 3-Year average Operating Cash Flow per Share Growth Rate was 37.90% per year. The lowest was 14.30% per year. And the median was 26.10% per year.

Haleon Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Haleon's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Price-to-Operating-Cash-Flow Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

14.68

14.17

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial								14.68	-	-	-	14.17

Competitive Comparison of Haleon's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Haleon's Price-to-Operating-Cash-Flow falls into.

Haleon Price-to-Operating-Cash-Flow Calculation

Haleon's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	3.296	/	0
	=

Haleon's Share Price of today is £3.296.
Haleon's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Haleon Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Haleon's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (LSE:HLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.